Single cell transcriptomics of HIV persistence and latency
HIV持续性和潜伏期的单细胞转录组学
基本信息
- 批准号:10570277
- 负责人:
- 金额:$ 62.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-03-19 至 2026-02-28
- 项目状态:未结题
- 来源:
- 关键词:AcuteAnimal ModelAnimalsAntibodiesBar CodesBehaviorBindingBiologicalBiological ModelsCD4 Positive T LymphocytesCell CommunicationCell CountCell LineageCell SurvivalCellsCellular Indexing of Transcriptomes and Epitopes by SequencingClassificationDevelopmentDisease ProgressionGastrointestinal tract structureGene Expression ProfileGenesGenetic TranscriptionGenomicsHIVHIV InfectionsHIV-1HumanImageImmune systemImmunologic Deficiency SyndromesIn VitroInfectionInterruptionInterventionKnowledgeMapsMeasuresMemoryMethodsModelingMorphologyMucous MembraneMusPathway AnalysisPathway interactionsPatternPharmaceutical PreparationsPhenotypeProliferatingRelapseResearchResolutionShockSpleenStimulusSuperantigensSystemSystems BiologyT-Cell ActivationT-LymphocyteTCR ActivationTestingTimeTissue-Specific Gene ExpressionTissuesViralViral reservoirVirusVirus Replicationacute infectionantiretroviral therapyhumanized mouseimprovedin vivomigrationmouse modelmultiple omicsnovelpreservationpreventprogramspurgeresponsesingle-cell RNA sequencingtranscriptomics
项目摘要
Summary
Antiretroviral therapy (ART) in HIV-1 infection suppresses viral replication, preserves and improves the
CD4+ T cell count and prevents disease progression. However, treatment with ART is not curative, and
interruption of therapy consistently unleashes viral relapse. The persistence of a viral reservoir following ART
is the major obstacle to an HIV cure. Proposed “shock and kill” strategies to activate and eliminate the HIV
reservoir are currently not informed by a knowledge of the T cell states or lineages that support latency. One
of the greatest challenges in latency research is to distinguish latent cells from non-latent cells, which is
inherently difficult to do without perturbing the latent state of the cells. With current approaches, cellular
activation is required to enumerate latent cells, which disrupts the very state that we would like to study. To
overcome this major roadblock to latency studies, we have developed an HIV-induced lineage tracing model
(HILT) in humanized mouse that irreversibly genetically marks infected cells. When combined with single cell
RNA sequencing (scRNAseq) approaches in HIV-infected, ART-treated animals, the result is an emerging
genomic resolution view of transcriptional states associated with HIV infection and latency. Preliminary studies
presented here begin to provide an unprecedented, single cell genomic classification of HIV-infected CD4 T
cell lineages and states during acute infection and during early antiretroviral treatment. In this proposal, we
explore single cell multi-omics of persistently infected human CD4 T cells in humanized mice and examine how
it responds to oligoclonal TCR activation versus homeostatic proliferation. The systems biology of T cells will
be used to dissect latent reservoirs in novel small animal models for HIV to understand how a reservoir is
generated and maintained in distinct cell states. Genomic analysis may be used to identify drugs or biologic
interventions that can push cells towards active HIV expression and are independent of cellular activation
state. These could be used to develop cure strategies aimed at enhancing expression and the progressive
decay of the latent reservoir. We hypothesize that a single cell multi-omics approach will elucidate
developmentally diverse T cell lineages and transcriptional states that harbor HIV reservoirs, and that each
cluster may display unique gene programs associated with HIV persistence. Reversing the expression of
factors associated with HIV persistence may reactivate the reservoir. Single cell multi-omics may unveil new
targeted strategies to purge HIV from different T cell states. The proposed study leverages a team with
expertise in HIV immunopathogenesis, humanized mice, single cell genomics, to deeply phenotype human T
cell reservoirs in novel small animal models.
概括
HIV-1 感染的抗逆转录病毒治疗 (ART) 可抑制病毒复制、保留和改善
CD4+ T 细胞计数并可预防疾病进展 然而,ART 治疗并不能治愈疾病,而且无法治愈。
治疗中断持续释放病毒复发 ART 后病毒库的持续存在。
是治疗艾滋病毒的主要障碍,建议采用“休克和杀死”策略来激活和消除艾滋病毒。
目前,储存库尚不了解支持潜伏期的 T 细胞状态或谱系。
潜伏研究中最大的挑战之一是区分潜伏细胞和非潜伏细胞,这是
就目前的方法而言,如果不扰乱细胞的潜伏状态,就很难做到这一点。
需要激活才能计数潜伏细胞,这破坏了我们想要研究的状态。
克服了潜伏期研究的这一主要障碍,我们开发了一种艾滋病毒诱导的谱系追踪模型
(HILT)在人源化小鼠中与单细胞结合时不可逆地对受感染的细胞进行基因标记。
RNA 测序 (scRNAseq) 方法用于感染 HIV 并接受 ART 治疗的动物,其结果是一种新兴的
与 HIV 感染和潜伏期相关的转录状态的基因组分辨率视图。
这里提出的开始提供前所未有的 HIV 感染 CD4 T 的单细胞基因组分类
急性感染期间和早期抗逆转录病毒治疗期间的细胞谱系和状态在本提案中。
探索人源化小鼠中持续感染的人类 CD4 T 细胞的单细胞多组学,并研究如何
它对寡克隆 TCR 激活和 T 细胞稳态增殖作出反应。
用于剖析新型艾滋病毒小动物模型中的潜在储存库,以了解储存库是如何存在的
以不同的细胞状态生成和维持的基因组分析可用于识别药物或生物制品。
可以推动细胞主动表达 HIV 且独立于细胞激活的干预措施
这些可用于制定旨在增强表达和进步的治疗策略。
我们发现单细胞多组学方法将阐明潜在储库的衰变。
发育上多样化的 T 细胞谱系和转录状态包含 HIV 储存库,并且每个
簇可能显示与逆转 HIV 持久性相关的独特基因程序。
与HIV持续存在相关的因素可能会重新激活病毒库。单细胞多组学可能会揭示新的病毒库。
拟议的研究利用了一个团队,以从不同的 T 细胞状态中清除 HIV。
HIV免疫发病机制、人源化小鼠、单细胞基因组学、深度人类T细胞表型方面的专业知识
新型小动物模型中的细胞储存库。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BENJAMIN K CHEN其他文献
BENJAMIN K CHEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BENJAMIN K CHEN', 18)}}的其他基金
Quantifying bNAb neutralization of the HIV latent reservoir
定量 HIV 潜伏库的 bNAb 中和作用
- 批准号:
10676564 - 财政年份:2023
- 资助金额:
$ 62.87万 - 项目类别:
Single cell transcriptomics of HIV persistence and latency
HIV持续性和潜伏期的单细胞转录组学
- 批准号:
10258566 - 财政年份:2021
- 资助金额:
$ 62.87万 - 项目类别:
Single cell transcriptomics of HIV persistence and latency
HIV持续性和潜伏期的单细胞转录组学
- 批准号:
10721393 - 财政年份:2021
- 资助金额:
$ 62.87万 - 项目类别:
Single cell transcriptomics of HIV persistence and latency
HIV持续性和潜伏期的单细胞转录组学
- 批准号:
10600389 - 财政年份:2021
- 资助金额:
$ 62.87万 - 项目类别:
Single cell transcriptomics of HIV persistence and latency
HIV持续性和潜伏期的单细胞转录组学
- 批准号:
10375603 - 财政年份:2021
- 资助金额:
$ 62.87万 - 项目类别:
HIV immune evasion and escape through T cell virological synapses
HIV通过T细胞病毒学突触逃避免疫
- 批准号:
10484093 - 财政年份:2020
- 资助金额:
$ 62.87万 - 项目类别:
相似国自然基金
探索在急性呼吸窘迫综合征动物模型和患者长时间俯卧位通气过程中动态滴定呼气末正压的意义
- 批准号:82270081
- 批准年份:2022
- 资助金额:76 万元
- 项目类别:面上项目
建立脑内急性基因编辑的孤独症非人灵长类动物模型
- 批准号:
- 批准年份:2019
- 资助金额:100 万元
- 项目类别:专项基金项目
树鼩异种移植模型的建立及免疫排斥机制的深入研究
- 批准号:81771721
- 批准年份:2017
- 资助金额:80.0 万元
- 项目类别:面上项目
染色体大片段缺失的急性髓性白血病动物模型的构建及分析
- 批准号:81770157
- 批准年份:2017
- 资助金额:84.0 万元
- 项目类别:面上项目
自发性高甘油三酯急性胰腺炎大鼠模型的建立及应用
- 批准号:81570584
- 批准年份:2015
- 资助金额:85.0 万元
- 项目类别:面上项目
相似海外基金
Prototype development and validation of soft robotic sensor arrays for mapping cardiac arrhythmia
用于绘制心律失常的软机器人传感器阵列的原型开发和验证
- 批准号:
10722857 - 财政年份:2023
- 资助金额:
$ 62.87万 - 项目类别:
Understanding and Controlling the Contribution of Fibrinolysis to Bleeding Using a Long-Acting Antifibrinolytic RNA Therapy
使用长效抗纤溶 RNA 疗法了解和控制纤溶对出血的影响
- 批准号:
10737327 - 财政年份:2023
- 资助金额:
$ 62.87万 - 项目类别:
Mentoring Emerging Researchers at CHLA (MERCH-LA)
指导 CHLA (MERCH-LA) 的新兴研究人员
- 批准号:
10797938 - 财政年份:2023
- 资助金额:
$ 62.87万 - 项目类别:
Developing a novel class of peptide antibiotics targeting carbapenem-resistant Gram-negative organisms
开发一类针对碳青霉烯类耐药革兰氏阴性生物的新型肽抗生素
- 批准号:
10674131 - 财政年份:2023
- 资助金额:
$ 62.87万 - 项目类别:
Systems Genetics of Cocaine Preference in Drosophila
果蝇可卡因偏好的系统遗传学
- 批准号:
10675195 - 财政年份:2023
- 资助金额:
$ 62.87万 - 项目类别: